title: [TNF-blockade--new strategy in difficult-to-treat asthma].
authors.affiliation: Centrum för allergiforskning, Karolinska institutet, Stockholm. sven-erik.dahlen@ki.se
authors.forename: Sven-Erik
authors.initials: SE
authors.lastname: Dahlén
authors.forename: Eva
authors.initials: E
authors.lastname: Millinger
authors.forename: Maria
authors.initials: M
authors.lastname: Skedinger
authors.forename: Olle
authors.initials: O
authors.lastname: Zetterström
authors.forename: Barbro
authors.initials: B
authors.lastname: Dahlén
mesh_terms: D018927:Anti-Asthmatic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy*; D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects / Q000627:therapeutic use; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D018927:Anti-Asthmatic Agents; D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D007155:Immunologic Factors; D014409:Tumor Necrosis Factor-alpha